Across TCGA pan-cancer cohorts, CNFN RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated CNFN data layer compared with 5 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher CNFN RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CNFN expression acts as an unfavorable survival marker, although some lineages such as CESC and HNSC show a favorable association.
CESC, UCS, and SKCM are the cancer types where CNFN RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.